Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gideon Koren

Showing results (31-40 of 1,106) with videos related to

Pageof 111
Sort By:
Neurotoxicology and Teratology|April 19, 2020
WITHDRAWN: Poster presentationsGideon Koren
Paediatric Drugs|January 9, 2009
Training clinicians in Maternal-Fetal Pharmacology: closing a conceptual gapGideon Koren
Canadian Family Physician Medecin De Famille Canadien|February 7, 2007
Changes in drug handling during pregnancy: what it might mean for your patientsGideon Koren
Paediatrics & Child Health|November 26, 2008
A primer of paediatric toxic syndromes or 'toxidromes'Gideon Koren
Obstetrics and Gynecology|May 25, 2011
Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum painGideon Koren
The Israel Journal of Psychiatry and Related Sciences|November 6, 2014
Maternal depression and perception of teratogenic riskGideon Koren
Paediatric Drugs|November 20, 2014
A practical approach to risk-benefit estimation in pediatric drug researchGideon Koren
Cancer Epidemiology|May 25, 2020
Assisted reproductive technology and the risk of pediatric cancer: Response to Reigstad et alGideon Koren
IRB|March 1, 1992
The eutectic mixture of local anesthetics: changing the risk-benefit ratio in pediatric researchGideon Koren
Canadian Family Physician Medecin De Famille Canadien|August 16, 2011
Folic acid and colorectal cancer: unwarranted fearsGideon Koren
Pageof 111

Showing results (31-40 of 1,106) with videos related to

Sort By:
Pageof 111
Neurotoxicology and Teratology|April 19, 2020
WITHDRAWN: Poster presentationsGideon Koren
Paediatric Drugs|January 9, 2009
Training clinicians in Maternal-Fetal Pharmacology: closing a conceptual gapGideon Koren
Canadian Family Physician Medecin De Famille Canadien|February 7, 2007
Changes in drug handling during pregnancy: what it might mean for your patientsGideon Koren
Paediatrics & Child Health|November 26, 2008
A primer of paediatric toxic syndromes or 'toxidromes'Gideon Koren
Obstetrics and Gynecology|May 25, 2011
Breast milk hydrocodone and hydromorphone levels in mothers using hydrocodone for postpartum painGideon Koren
The Israel Journal of Psychiatry and Related Sciences|November 6, 2014
Maternal depression and perception of teratogenic riskGideon Koren
Paediatric Drugs|November 20, 2014
A practical approach to risk-benefit estimation in pediatric drug researchGideon Koren
Cancer Epidemiology|May 25, 2020
Assisted reproductive technology and the risk of pediatric cancer: Response to Reigstad et alGideon Koren
IRB|March 1, 1992
The eutectic mixture of local anesthetics: changing the risk-benefit ratio in pediatric researchGideon Koren
Canadian Family Physician Medecin De Famille Canadien|August 16, 2011
Folic acid and colorectal cancer: unwarranted fearsGideon Koren
Pageof 111